Clinical Trials Browser

amino-acid, glucose, and electrolyte solution × Endocrine × Clear all

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Rhabdomyosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroendocrine Tumors

NCT04919226 2025-09-10

COMPOSE

Phase 3 Active not recruiting

259 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT06878664 2025-09-02

RIALTO

Phase 3 Recruiting

166 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT03049189 2025-05-30

COMPETE

Phase 3 Active not recruiting

309 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05475210 2024-03-13

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

Phase 1 Recruiting

9 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT02592707 2023-07-19

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

Phase 1/2 Terminated

40 enrolled 37 charts

EndocrineNET

Neuroendocrine Tumors

Clinical Trials

KinLET

COMPOSE

RIALTO

COMPETE

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs